Global and United States Xerostomia (Dry Mouth) Therapeutics Market Report & Forecast 2024-2031

Report ID: 1835470 | Published Date: Jan 2025 | No. of Page: 103 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Xerostomia (Dry Mouth) Therapeutics Product Introduction
    1.2 Global Xerostomia (Dry Mouth) Therapeutics Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume for the Year 2017-2028
    1.3 United States Xerostomia (Dry Mouth) Therapeutics Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Xerostomia (Dry Mouth) Therapeutics Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Xerostomia (Dry Mouth) Therapeutics Sales in Volume for the Year 2017-2028
    1.4 Xerostomia (Dry Mouth) Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Xerostomia (Dry Mouth) Therapeutics in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Xerostomia (Dry Mouth) Therapeutics Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Xerostomia (Dry Mouth) Therapeutics Market Dynamics
        1.5.1 Xerostomia (Dry Mouth) Therapeutics Industry Trends
        1.5.2 Xerostomia (Dry Mouth) Therapeutics Market Drivers
        1.5.3 Xerostomia (Dry Mouth) Therapeutics Market Challenges
        1.5.4 Xerostomia (Dry Mouth) Therapeutics Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Xerostomia (Dry Mouth) Therapeutics Market Segment by Type
        2.1.1 Salivary Stimulants
        2.1.2 Salivary Substitutes
        2.1.3 Dentifrices
    2.2 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Type
        2.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Xerostomia (Dry Mouth) Therapeutics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Xerostomia (Dry Mouth) Therapeutics Market Size by Type
        2.3.1 United States Xerostomia (Dry Mouth) Therapeutics Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Xerostomia (Dry Mouth) Therapeutics Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Xerostomia (Dry Mouth) Therapeutics Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Xerostomia (Dry Mouth) Therapeutics Market Segment by Application
        3.1.1 OTC
        3.1.2 Prescription
    3.2 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Application
        3.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Xerostomia (Dry Mouth) Therapeutics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Xerostomia (Dry Mouth) Therapeutics Market Size by Application
        3.3.1 United States Xerostomia (Dry Mouth) Therapeutics Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Xerostomia (Dry Mouth) Therapeutics Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Xerostomia (Dry Mouth) Therapeutics Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Xerostomia (Dry Mouth) Therapeutics Competitor Landscape by Company
    4.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Company
        4.1.1 Top Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturer (2017-2022)
        4.1.3 Global Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturer (2017-2022)
        4.1.4 Global Xerostomia (Dry Mouth) Therapeutics Price by Manufacturer (2017-2022)
    4.2 Global Xerostomia (Dry Mouth) Therapeutics Concentration Ratio (CR)
        4.2.1 Xerostomia (Dry Mouth) Therapeutics Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Xerostomia (Dry Mouth) Therapeutics in 2021
        4.2.3 Global Xerostomia (Dry Mouth) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Xerostomia (Dry Mouth) Therapeutics Manufacturing Base Distribution, Product Type
        4.3.1 Global Xerostomia (Dry Mouth) Therapeutics Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
        4.3.3 Date of International Manufacturers Enter into Xerostomia (Dry Mouth) Therapeutics Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Xerostomia (Dry Mouth) Therapeutics Market Size by Company
        4.5.1 Top Xerostomia (Dry Mouth) Therapeutics Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Xerostomia (Dry Mouth) Therapeutics Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Xerostomia (Dry Mouth) Therapeutics Sales by Players (2020, 2021 & 2022)
5 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Region
    5.1 Global Xerostomia (Dry Mouth) Therapeutics Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Xerostomia (Dry Mouth) Therapeutics Market Size in Volume by Region (2017-2028)
        5.2.1 Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Region: 2017-2022
        5.2.2 Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Xerostomia (Dry Mouth) Therapeutics Market Size in Value by Region (2017-2028)
        5.3.1 Global Xerostomia (Dry Mouth) Therapeutics Sales in Value by Region: 2017-2022
        5.3.2 Global Xerostomia (Dry Mouth) Therapeutics Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Xerostomia (Dry Mouth) Therapeutics Market Size YoY Growth 2017-2028
        6.1.2 North America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Indonesia
        6.2.9 Thailand
        6.2.10 Malaysia
        6.2.11 Philippines
        6.2.12 Vietnam
    6.3 Europe
        6.3.1 Europe Xerostomia (Dry Mouth) Therapeutics Market Size YoY Growth 2017-2028
        6.3.2 Europe Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 UK
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Xerostomia (Dry Mouth) Therapeutics Market Size YoY Growth 2017-2028
        6.4.2 Latin America Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Brazil
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE
7 Company Profiles
    7.1 GlaxoSmithKline plc
        7.1.1 GlaxoSmithKline plc Corporation Information
        7.1.2 GlaxoSmithKline plc Description and Business Overview
        7.1.3 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.1.5 GlaxoSmithKline plc Recent Development
    7.2 Church & Dwight, Inc.
        7.2.1 Church & Dwight, Inc. Corporation Information
        7.2.2 Church & Dwight, Inc. Description and Business Overview
        7.2.3 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.2.5 Church & Dwight, Inc. Recent Development
    7.3 Colgate-Palmolive Company
        7.3.1 Colgate-Palmolive Company Corporation Information
        7.3.2 Colgate-Palmolive Company Description and Business Overview
        7.3.3 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.3.5 Colgate-Palmolive Company Recent Development
    7.4 Hikma Pharmaceuticals PLC
        7.4.1 Hikma Pharmaceuticals PLC Corporation Information
        7.4.2 Hikma Pharmaceuticals PLC Description and Business Overview
        7.4.3 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.4.5 Hikma Pharmaceuticals PLC Recent Development
    7.5 Pendopharm
        7.5.1 Pendopharm Corporation Information
        7.5.2 Pendopharm Description and Business Overview
        7.5.3 Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Pendopharm Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.5.5 Pendopharm Recent Development
    7.6 Sun Pharmaceuticals Industries Ltd.
        7.6.1 Sun Pharmaceuticals Industries Ltd. Corporation Information
        7.6.2 Sun Pharmaceuticals Industries Ltd. Description and Business Overview
        7.6.3 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.6.5 Sun Pharmaceuticals Industries Ltd. Recent Development
    7.7 Lupin Pharmaceuticals, Inc.
        7.7.1 Lupin Pharmaceuticals, Inc. Corporation Information
        7.7.2 Lupin Pharmaceuticals, Inc. Description and Business Overview
        7.7.3 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.7.5 Lupin Pharmaceuticals, Inc. Recent Development
    7.8 Pfizer, Inc.
        7.8.1 Pfizer, Inc. Corporation Information
        7.8.2 Pfizer, Inc. Description and Business Overview
        7.8.3 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.8.5 Pfizer, Inc. Recent Development
    7.9 Parnell Pharmaceuticals, Inc.
        7.9.1 Parnell Pharmaceuticals, Inc. Corporation Information
        7.9.2 Parnell Pharmaceuticals, Inc. Description and Business Overview
        7.9.3 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.9.5 Parnell Pharmaceuticals, Inc. Recent Development
    7.10 Acacia Pharma
        7.10.1 Acacia Pharma Corporation Information
        7.10.2 Acacia Pharma Description and Business Overview
        7.10.3 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.10.5 Acacia Pharma Recent Development
    7.11 OraCoat
        7.11.1 OraCoat Corporation Information
        7.11.2 OraCoat Description and Business Overview
        7.11.3 OraCoat Xerostomia (Dry Mouth) Therapeutics Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 OraCoat Xerostomia (Dry Mouth) Therapeutics Products Offered
        7.11.5 OraCoat Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Xerostomia (Dry Mouth) Therapeutics Industry Chain Analysis
    8.2 Xerostomia (Dry Mouth) Therapeutics Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Xerostomia (Dry Mouth) Therapeutics Distributors
    8.3 Xerostomia (Dry Mouth) Therapeutics Production Mode & Process
    8.4 Xerostomia (Dry Mouth) Therapeutics Sales and Marketing
        8.4.1 Xerostomia (Dry Mouth) Therapeutics Sales Channels
        8.4.2 Xerostomia (Dry Mouth) Therapeutics Distributors
    8.5 Xerostomia (Dry Mouth) Therapeutics Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Xerostomia (Dry Mouth) Therapeutics CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Xerostomia (Dry Mouth) Therapeutics Market Trends
    Table 3. Xerostomia (Dry Mouth) Therapeutics Market Drivers
    Table 4. Xerostomia (Dry Mouth) Therapeutics Market Challenges
    Table 5. Xerostomia (Dry Mouth) Therapeutics Market Restraints
    Table 6. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Xerostomia (Dry Mouth) Therapeutics Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Xerostomia (Dry Mouth) Therapeutics Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Xerostomia (Dry Mouth) Therapeutics Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Xerostomia (Dry Mouth) Therapeutics Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Xerostomia (Dry Mouth) Therapeutics Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Xerostomia (Dry Mouth) Therapeutics Sales by Manufacturer, (K MT), 2017-2022
    Table 14. Global Xerostomia (Dry Mouth) Therapeutics Sales Share by Manufacturer, 2017-2022
    Table 15. Global Xerostomia (Dry Mouth) Therapeutics Price by Manufacturer (2017-2022) & (USD/MT)
    Table 16. Global Xerostomia (Dry Mouth) Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Xerostomia (Dry Mouth) Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Xerostomia (Dry Mouth) Therapeutics as of 2021)
    Table 18. Top Players of Xerostomia (Dry Mouth) Therapeutics in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Xerostomia (Dry Mouth) Therapeutics Product Type
    Table 20. Date of International Manufacturers Enter into Xerostomia (Dry Mouth) Therapeutics Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Xerostomia (Dry Mouth) Therapeutics Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Xerostomia (Dry Mouth) Therapeutics Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Xerostomia (Dry Mouth) Therapeutics Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Xerostomia (Dry Mouth) Therapeutics Sales by Players, (K MT), 2020, 2021 & 2022
    Table 26. United States Xerostomia (Dry Mouth) Therapeutics Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Xerostomia (Dry Mouth) Therapeutics Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Region (2017-2022) & (K MT)
    Table 29. Global Xerostomia (Dry Mouth) Therapeutics Sales in Volume Forecast by Region (2023-2028) & (K MT)
    Table 30. Global Xerostomia (Dry Mouth) Therapeutics Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Xerostomia (Dry Mouth) Therapeutics Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Country (2017-2028) & (K MT)
    Table 33. North America Xerostomia (Dry Mouth) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Region (2017-2028) & (K MT)
    Table 35. Asia Pacific Xerostomia (Dry Mouth) Therapeutics Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Country (2017-2028) & (K MT)
    Table 37. Europe Xerostomia (Dry Mouth) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Country (2017-2028) & (K MT)
    Table 39. Latin Americaa Xerostomia (Dry Mouth) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales in Volume by Country (2017-2028) & (K MT)
    Table 41. Middle East and Africa Xerostomia (Dry Mouth) Therapeutics Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. GlaxoSmithKline plc Corporation Information
    Table 43. GlaxoSmithKline plc Description and Business Overview
    Table 44. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 45. GlaxoSmithKline plc Xerostomia (Dry Mouth) Therapeutics Product
    Table 46. GlaxoSmithKline plc Recent Development
    Table 47. Church & Dwight, Inc. Corporation Information
    Table 48. Church & Dwight, Inc. Description and Business Overview
    Table 49. Church & Dwight, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 50. Church & Dwight, Inc. Product
    Table 51. Church & Dwight, Inc. Recent Development
    Table 52. Colgate-Palmolive Company Corporation Information
    Table 53. Colgate-Palmolive Company Description and Business Overview
    Table 54. Colgate-Palmolive Company Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 55. Colgate-Palmolive Company Product
    Table 56. Colgate-Palmolive Company Recent Development
    Table 57. Hikma Pharmaceuticals PLC Corporation Information
    Table 58. Hikma Pharmaceuticals PLC Description and Business Overview
    Table 59. Hikma Pharmaceuticals PLC Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 60. Hikma Pharmaceuticals PLC Product
    Table 61. Hikma Pharmaceuticals PLC Recent Development
    Table 62. Pendopharm Corporation Information
    Table 63. Pendopharm Description and Business Overview
    Table 64. Pendopharm Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 65. Pendopharm Product
    Table 66. Pendopharm Recent Development
    Table 67. Sun Pharmaceuticals Industries Ltd. Corporation Information
    Table 68. Sun Pharmaceuticals Industries Ltd. Description and Business Overview
    Table 69. Sun Pharmaceuticals Industries Ltd. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 70. Sun Pharmaceuticals Industries Ltd. Product
    Table 71. Sun Pharmaceuticals Industries Ltd. Recent Development
    Table 72. Lupin Pharmaceuticals, Inc. Corporation Information
    Table 73. Lupin Pharmaceuticals, Inc. Description and Business Overview
    Table 74. Lupin Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 75. Lupin Pharmaceuticals, Inc. Product
    Table 76. Lupin Pharmaceuticals, Inc. Recent Development
    Table 77. Pfizer, Inc. Corporation Information
    Table 78. Pfizer, Inc. Description and Business Overview
    Table 79. Pfizer, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 80. Pfizer, Inc. Product
    Table 81. Pfizer, Inc. Recent Development
    Table 82. Parnell Pharmaceuticals, Inc. Corporation Information
    Table 83. Parnell Pharmaceuticals, Inc. Description and Business Overview
    Table 84. Parnell Pharmaceuticals, Inc. Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 85. Parnell Pharmaceuticals, Inc. Product
    Table 86. Parnell Pharmaceuticals, Inc. Recent Development
    Table 87. Acacia Pharma Corporation Information
    Table 88. Acacia Pharma Description and Business Overview
    Table 89. Acacia Pharma Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 90. Acacia Pharma Product
    Table 91. Acacia Pharma Recent Development
    Table 92. OraCoat Corporation Information
    Table 93. OraCoat Description and Business Overview
    Table 94. OraCoat Xerostomia (Dry Mouth) Therapeutics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
    Table 95. OraCoat Product
    Table 96. OraCoat Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Xerostomia (Dry Mouth) Therapeutics Customers List
    Table 100. Xerostomia (Dry Mouth) Therapeutics Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Xerostomia (Dry Mouth) Therapeutics Product Picture
    Figure 2. Global Xerostomia (Dry Mouth) Therapeutics Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Xerostomia (Dry Mouth) Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 4. Global Xerostomia (Dry Mouth) Therapeutics Sales 2017-2028 (K MT)
    Figure 5. United States Xerostomia (Dry Mouth) Therapeutics Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Xerostomia (Dry Mouth) Therapeutics Market Size 2017-2028 (US$ Million)
    Figure 7. United States Xerostomia (Dry Mouth) Therapeutics Sales 2017-2028 (K MT)
    Figure 8. United States Xerostomia (Dry Mouth) Therapeutics Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Xerostomia (Dry Mouth) Therapeutics Market Share in Global, in Volume (K MT) 2017-2028
    Figure 10. Xerostomia (Dry Mouth) Therapeutics Report Years Considered
    Figure 11. Product Picture of Salivary Stimulants
    Figure 12. Product Picture of Salivary Substitutes
    Figure 13. Product Picture of Dentifrices
    Figure 14. Global Xerostomia (Dry Mouth) Therapeutics Market Share by Type in 2022 & 2028
    Figure 15. Global Xerostomia (Dry Mouth) Therapeutics Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 16. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Type (2017-2028)
    Figure 17. Global Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2028) & (K MT)
    Figure 18. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Type (2017-2028)
    Figure 19. Global Xerostomia (Dry Mouth) Therapeutics Price by Type (2017-2028) & (USD/MT)
    Figure 20. United States Xerostomia (Dry Mouth) Therapeutics Market Share by Type in 2022 & 2028
    Figure 21. United States Xerostomia (Dry Mouth) Therapeutics Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 22. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Type (2017-2028)
    Figure 23. United States Xerostomia (Dry Mouth) Therapeutics Sales by Type (2017-2028) & (K MT)
    Figure 24. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Type (2017-2028)
    Figure 25. United States Xerostomia (Dry Mouth) Therapeutics Price by Type (2017-2028) & (USD/MT)
    Figure 26. Product Picture of OTC
    Figure 27. Product Picture of Prescription
    Figure 28. Global Xerostomia (Dry Mouth) Therapeutics Market Share by Application in 2022 & 2028
    Figure 29. Global Xerostomia (Dry Mouth) Therapeutics Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 30. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Application (2017-2028)
    Figure 31. Global Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2028) & (K MT)
    Figure 32. Global Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Application (2017-2028)
    Figure 33. Global Xerostomia (Dry Mouth) Therapeutics Price by Application (2017-2028) & (USD/MT)
    Figure 34. United States Xerostomia (Dry Mouth) Therapeutics Market Share by Application in 2022 & 2028
    Figure 35. United States Xerostomia (Dry Mouth) Therapeutics Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Value by Application (2017-2028)
    Figure 37. United States Xerostomia (Dry Mouth) Therapeutics Sales by Application (2017-2028) & (K MT)
    Figure 38. United States Xerostomia (Dry Mouth) Therapeutics Sales Market Share in Volume by Application (2017-2028)
    Figure 39. United States Xerostomia (Dry Mouth) Therapeutics Price by Application (2017-2028) & (USD/MT)
    Figure 40. North America Xerostomia (Dry Mouth) Therapeutics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 41. North America Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 42. United States Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Canada Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Mexico Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Xerostomia (Dry Mouth) Therapeutics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 46. Europe Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. UK Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 53. Asia-Pacific Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. Indonesia Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Thailand Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Malaysia Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Philippines Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Vietnam Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Latin America Xerostomia (Dry Mouth) Therapeutics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 65. Latin America Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 66. Brazil Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales in Volume Growth Rate 2017-2028 (K MT)
    Figure 68. Middle East & Africa Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 69. Turkey Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 70. Saudi Arabia Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 71. UAE Xerostomia (Dry Mouth) Therapeutics Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Xerostomia (Dry Mouth) Therapeutics Value Chain
    Figure 73. Xerostomia (Dry Mouth) Therapeutics Production Process
    Figure 74. Channels of Distribution
    Figure 75. Distributors Profiles
    Figure 76. Bottom-up and Top-down Approaches for This Report
    Figure 77. Data Triangulation
    Figure 78. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline plc
Church & Dwight, Inc.
Colgate-Palmolive Company
Hikma Pharmaceuticals PLC
Pendopharm
Sun Pharmaceuticals Industries Ltd.
Lupin Pharmaceuticals, Inc.
Pfizer, Inc.
Parnell Pharmaceuticals, Inc.
Acacia Pharma
OraCoat
Frequently Asked Questions
Xerostomia (Dry Mouth) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Xerostomia (Dry Mouth) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Xerostomia (Dry Mouth) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Brachytherapy

Brachytherapy market is segmented by region (country), players, by Type and by Application. Playe ... Read More